NASDAQ:ICUI

ICU Medical Stock Forecast, Price & News

$238.83
-0.69 (-0.29 %)
(As of 09/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$237.46
$242.00
50-Day Range
$186.80
$260.00
52-Week Range
$176.18
$282.00
Volume141,750 shs
Average Volume143,108 shs
Market Capitalization$5.07 billion
P/E Ratio50.07
Dividend YieldN/A
Beta0.6
30 days | 90 days | 365 days | Advanced Chart
Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.


ICU Medical logo

About ICU Medical

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Headlines

ICU Medical: Decisive M&A, Again
ICU Medical: Decisive M&A, Again
September 10, 2021 |  seekingalpha.com
Company News for Sep 9, 2021
Company News for Sep 9, 2021
September 9, 2021 |  finance.yahoo.com
KeyCorp Raises ICU Medical (NASDAQ:ICUI) Price Target to $302.00
KeyCorp Raises ICU Medical (NASDAQ:ICUI) Price Target to $302.00
September 9, 2021 |  americanbankingnews.com
Why ICU Medical Shares Surged Today
Why ICU Medical Shares Surged Today
September 8, 2021 |  benzinga.com
ICU Medical (NASDAQ:ICUI) Sets New 52-Week High at $269.27
ICU Medical (NASDAQ:ICUI) Sets New 52-Week High at $269.27
September 8, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.13 out of 5 stars

Medical Sector

430th out of 1,352 stocks

Surgical & Medical Instruments Industry

43rd out of 123 stocks

Analyst Opinion: 2.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

Is ICU Medical a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICU Medical stock.
View analyst ratings for ICU Medical
or view top-rated stocks.

What stocks does MarketBeat like better than ICU Medical?

Wall Street analysts have given ICU Medical a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ICU Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for ICU Medical
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) released its quarterly earnings data on Wednesday, August, 4th. The medical instruments supplier reported $1.57 EPS for the quarter, topping the consensus estimate of $1.43 by $0.14. The medical instruments supplier earned $321.68 million during the quarter, compared to the consensus estimate of $306.30 million. ICU Medical had a net margin of 8.07% and a trailing twelve-month return on equity of 8.67%.
View ICU Medical's earnings history
.

How has ICU Medical's stock price been impacted by COVID-19?

ICU Medical's stock was trading at $180.56 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ICUI stock has increased by 32.3% and is now trading at $238.83.
View which stocks have been most impacted by COVID-19
.

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical issued an update on its FY 2021 earnings guidance on Wednesday, August, 25th. The company provided EPS guidance of $6.800-$7.200 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.930. The company issued revenue guidance of -.

What price target have analysts set for ICUI?

2 analysts have issued twelve-month price objectives for ICU Medical's shares. Their forecasts range from $286.00 to $302.00. On average, they anticipate ICU Medical's share price to reach $294.00 in the next year. This suggests a possible upside of 23.1% from the stock's current price.
View analysts' price targets for ICU Medical
or view top-rated stocks among Wall Street analysts.

Who are ICU Medical's key executives?

ICU Medical's management team includes the following people:
  • Vivek Jain, Chairman & Chief Executive Officer
  • Christian Voigtlander, Chief Operating Officer
  • Brian M. Bonnell, Chief Financial Officer & Treasurer
  • Krishna Uppugonduri, VP-Quality, Medical & Regulatory Affairs
  • Virginia Sanzone, Secretary, Vice President & General Counsel (LinkedIn Profile)

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical CEO Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among ICU Medical's employees.

Who are some of ICU Medical's key competitors?

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), The Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (11.21%), Vanguard Group Inc. (8.77%), BlackRock Inc. (7.86%), Nuance Investments LLC (6.42%), JPMorgan Chase & Co. (4.22%) and Findlay Park Partners LLP (3.09%). Company insiders that own ICU Medical stock include Elisha W Finney, George A Lopez, Robert S Swinney, Scott E Lamb, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends for ICU Medical
.

Which major investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Point72 Asset Management L.P., PFM Health Sciences LP, BlackRock Inc., Tamarack Advisers LP, Woodline Partners LP, BNP Paribas Arbitrage SA, and American Century Companies Inc.. Company insiders that have sold ICU Medical company stock in the last year include Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone, and Vivek Jain.
View insider buying and selling activity for ICU Medical
or view top insider-selling stocks.

Which major investors are buying ICU Medical stock?

ICUI stock was bought by a variety of institutional investors in the last quarter, including Nuance Investments LLC, Kennedy Capital Management Inc., Victory Capital Management Inc., WCM Investment Management LLC, Eagle Asset Management Inc., Dimensional Fund Advisors LP, State Street Corp, and Segall Bryant & Hamill LLC.
View insider buying and selling activity for ICU Medical
or or view top insider-buying stocks.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $238.83.

How much money does ICU Medical make?

ICU Medical has a market capitalization of $5.07 billion and generates $1.27 billion in revenue each year. The medical instruments supplier earns $86.87 million in net income (profit) each year or $6.13 on an earnings per share basis.

How many employees does ICU Medical have?

ICU Medical employs 7,900 workers across the globe.

When was ICU Medical founded?

ICU Medical was founded in 1984.

What is ICU Medical's official website?

The official website for ICU Medical is www.icumed.com.

Where are ICU Medical's headquarters?

ICU Medical is headquartered at 951 CALLE AMANECER, SAN CLEMENTE CA, 92763.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at (949) 366-2183 or via email at [email protected].


This page was last updated on 9/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.